TNFRSF10B and type 2 diabetes mellitus: Another interesting piece of evidence provided in a large-scale Swedish epidemiological study is that patients with T2DM display elevated plasma levels of soluble TRAIL-R2 serving as a surrogate marker of endogenous TRAIL effect neutralization [86].